BAX and nasopharyngeal carcinoma: Perhaps even more important was the finding that NPC patients without distant metastases are less likely to relapse when their tumor is BAX mRNA-positive, compared to metastasis-free patients with a BAX-negative nasopharyngeal malignancy.